Stanley M. Rogoff, 1922-1979.

N. Jones

DOI: https://doi.org/10.2214/ajr.133.6.1207

1979-12-01

Abstract:

What problem does this paper attempt to address?

Polycystic ovary syndrome and autism: A test of the prenatal sex steroid theory

Adriana Cherskov,Alexa Pohl,Carrie Allison,Heping Zhang,Rupert A Payne,Simon Baron-Cohen

DOI: https://doi.org/10.1038/s41398-018-0186-7

2018-08-01

Abstract:Elevated levels of prenatal testosterone may increase the risk for autism spectrum conditions (autism). Given that polycystic ovary syndrome (PCOS) is also associated with elevated prenatal testosterone and its precursor sex steroids, a hypothesis from the prenatal sex steroid theory is that women with PCOS should have elevated autistic traits and a higher rate of autism among their children. Using electronic health records obtained from the Clinical Practice Research Datalink (CPRD) in the UK between 1990 and 2014, we conducted three matched case-control studies. Studies 1 and 2 examined the risk of PCOS in women with autism (n = 971) and the risk of autism in women with PCOS (n = 26,263), respectively, compared with matched controls. Study 3 examined the odds ratio (OR) of autism in first-born children of women with PCOS (n = 8588), matched to 41,127 controls. In Studies 1 and 2 we found increased prevalence of PCOS in women with autism (2.3% vs. 1.1%; unadjusted OR: 2.01, 95% CI: 1.22-3.30) and elevated rates of autism in women with PCOS (0.17% vs. 0.09%, unadjusted OR: 1.94 CI: 1.37-2.76). In Study 3 we found the odds of having a child with autism were significantly increased, even after adjustment for maternal psychiatric diagnoses, obstetric complications, and maternal metabolic conditions (unadjusted OR: 1.60, 95% CI: 1.28-2.00; adjusted OR: 1.35, 95% CI: 1.06-1.73). These studies provide further evidence that women with PCOS and their children have a greater risk of autism.
Associations Between Sex Hormone Levels and Autistic Traits in Infertile Patients With Polycystic Ovary Syndrome and Their Offspring

Lijie Jiang,Li Tian,Jiajia Yuan,Xinjie Xu,Fan Qu,Rong Zhang,Jianliu Wang

DOI: https://doi.org/10.3389/fendo.2021.789395

IF: 6.055

2022-01-01

Frontiers in Endocrinology

Abstract:Objectives1) To explore the associations between autistic traits and sex hormone changes in patients with polycystic ovary syndrome (PCOS); 2) To explore the influence of PCOS parental autistic traits and related sex hormone changes on autistic traits in their offspring. MethodThis is a case-control study that recruited two groups: polycystic ovarian syndrome-induced infertile subjects as the observation group and fallopian tube factor-induced infertility subjects as the control group. Both cohorts were patients undergoing infertility treatment in the Productive Medicine Center, Peking University People's Hospital. Two types of questionnaires were completed by patients between May 1(st), 2015, and May 1(st), 2016: 1. The autism-spectrum quotient (AQ) 2. Repetitive behavior scale-revised (RBS-r). Levels of sex hormones in serum were measured in patients. The correlations between the levels of these biochemical factors and scores of the autistic traits were analysed. From July 1(st), 2020 to September 1(st), 2021, these patients were followed up by telephone and asked to fill out a questionnaire online. The questionnaire included date of delivery, complications, medicine used and negative events during pregnancy (e.g., death of relatives, divorce, etc.), delivery condition, breastfeeding, AQ scale and Autism Behavior Checklist (ABC) of their children. ResultsThe patients in the PCOS group had significantly higher AQ scores than those in the control group. Levels of luteinizing hormone and testosterone were also higher in the PCOS group. No significant differences were found between the two groups in RBS-r levels, follicle-stimulating hormone, estradiol or progesterone. In the two combined groups, there were significantly positive correlations between the AQ scores and the luteinizing hormone concentration, as well as between scores of RBS-r and testosterone concentration. Moreover, there was a significantly negative correlation between the level of progesterone and the RBS-r score. According to the follow-up data, the AQ scores of offspring were positively correlated with the RBS-r scores of their mothers. The ABC scores of offspring were positively correlated with the RBS-r scores and the childbearing age of their mothers. No significant difference was found between the two groups in age of delivery, complications, special medication used, negative events during pregnancy, delivery situation, postpartum breastfeeding, age of children, or AQ scores or ABC scores of children. There were no significant correlations between the scale scores of children and the related sex hormone levels of mothers. This could indicate that the higher levels of luteinizing hormone and testosterone and the lower level of progesterone accompanied more pronounced autistic traits in PCOS. Furthermore, the higher delivery age and RBS-r score in mothers accompanied the higher AQ and ABC scores in children. ConclusionCompared with the control group, PCOS patients had more autistic traits (especially social dysfunction). The autistic traits in PCOS patients might be related to the elevation in testosterone concentration and luteinizing hormone levels and the decline in progesterone level. Moreover, the autistic traits in the offspring of PCOS patients might be related to the parental high delivery age and high tendency to autism traits.
Prematurity and Genetic Liability for Autism Spectrum Disorder

Yali Zhang,Ashraf Yahia,Sven Sandin,Ulrika Åden,Kristiina Tammimies

DOI: https://doi.org/10.1101/2024.11.20.24317613

2024-11-20

Abstract:Background: Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by diverse presentations and a strong genetic component. Environmental factors, such as prematurity, have also been linked to increased liability for ASD, though the interaction between genetic predisposition and prematurity remains unclear. This study aims to investigate the impact of genetic liability and preterm birth on ASD conditions. Methods: We analyzed phenotype and genetic data from two large ASD cohorts, the Simons Foundation Powering Autism Research for Knowledge (SPARK) and Simons Simplex Collection (SSC), encompassing 78,559 individuals for phenotype analysis, 12,519 individuals with genome sequencing data, and 8,104 individuals with exome sequencing data. Statistical significance of differences in clinical measures were evaluated between individuals with different ASD and preterm status. We assessed the rare variants burden using generalized estimating equations (GEE) models and polygenic load using ASD-associated polygenic risk score (PRS). Furthermore, we developed a machine learning model to predict ASD in preterm children using phenotype and genetic features available at birth. Results: Individuals with both preterm birth and ASD exhibit more severe phenotypic outcomes despite similar levels of genetic liability for ASD across the term and preterm groups. Notable, preterm ASD individuals showed an elevated rate of de novo variants identified in exome sequencing (GEE model with Poisson family, p-value = 0.005) in comparison to the non-ASD preterm group. Additionally, a GEE model showed that a higher ASD PRS, preterm birth, and male sex were positively associated with a higher predicted probability for ASD, reaching a probability close to 90%. Lastly, we developed a machine learning model using phenotype and genetic features available at birth with limited predictive power (AUROC = 0.65). Conclusions: Preterm birth may exacerbate the multimorbidity present in ASD, which was not due to the ASD genetic factors. However, increased genetic factors may elevate the likelihood of a preterm child being diagnosed with ASD. Additionally, a polygenic load of ASD-associated variants had an additive role with preterm birth in the predicted probability for ASD, especially for boys. We propose that incorporating genetic assessment into neonatal care could benefit early ASD identification and intervention for preterm infants.
Contribution of autosomal rare and variants to sex differences in autism

Mahmoud Koko,F. Kyle Satterstrom,Autism Sequencing Consortium,APEX consortium,Varun Warrier,Hilary Martin

DOI: https://doi.org/10.1101/2024.04.13.24305713

2024-04-16

Abstract:Autism is four times more prevalent in males than females. To study whether this reflects a difference in genetic predisposition attributed to autosomal rare variants, we evaluated the sex differences in effect size of damaging protein-truncating and missense variants on autism predisposition in 47,061 autistic individuals, then compared effect sizes between individuals with and without cognitive impairment or motor delay. Although these variants mediated differential likelihood of autism with versus without motor or cognitive impairment, their effect sizes on the liability scale did not differ significantly by sex exome-wide or in genes sex-differentially expressed in the cortex. Although de novo mutations were enriched in genes with male-biased expression in the fetal cortex, the liability they conferred did not differ significantly from other genes with similar loss-of-function intolerance and sex-averaged cortical expression. In summary, autosomal rare coding variants confer similar liability for autism in females and males.

Psychiatry and Clinical Psychology
Genetic correlates of phenotypic heterogeneity in autism

Varun Warrier,Xinhe Zhang,Patrick Reed,Alexandra Havdahl,Tyler M. Moore,Freddy Cliquet,Claire S. Leblond,Thomas Rolland,Anders Rosengren,David H. Rowitch,Matthew E. Hurles,Daniel H. Geschwind,Anders D. Børglum,Elise B. Robinson,Jakob Grove,Hilary C. Martin,Thomas Bourgeron,Simon Baron-Cohen,Antonia San Jose Caceres,Hannah Hayward,Daisy Crawley,Jessica Faulkner,Jessica Sabet,Claire Ellis,Bethany Oakley,Eva Loth,Tony Charman,Declan Murphy,Rosemary Holt,Jack Waldman,Jessica Upadhyay,Nicola Gunby,Meng-Chuan Lai,Gwilym Renouf,Amber Ruigrok,Emily Taylor,Hisham Ziauddeen,Julia Deakin,Sara Ambrosino di Bruttopilo,Sarai van Dijk,Yvonne Rijks,Tabitha Koops,Miriam Douma,Alyssia Spaan,Iris Selten,Maarten Steffers,Anna Ver Loren van Themaat,Nico Bast,Sarah Baumeister,Larry O’Dwyer,Carsten Bours,Annika Rausch,Daniel von Rhein,Ineke Cornelissen,Yvette de Bruin,Maartje Graauwmans,Elzbieta Kostrzewa,Elodie Cauvet,Kristiina Tammimies,Rouslan Sitnikow,Guillaume Dumas,Yang-Min Kim,David M. Hougaard,Jonas Bybjerg-Grauholm,Thomas Werge,Preben Bo Mortensen,Ole Mors,Merete Nordentoft,Dwaipayan Adhya,Armandina Alamanza,Carrie Allison,Isabelle Garvey,Tracey Parsons,Paula Smith,Alex Tsompanidis,Graham J. Burton,Alexander E. P. Heazell,Lidia V. Gabis,Tal Biron-Shental,Madeline A. Lancaster,Deepak P. Srivastava,Jonathan Mill,EU-AIMS LEAP,iPSYCH-Autism Working Group,Spectrum 10K and APEX Consortia

DOI: https://doi.org/10.1038/s41588-022-01072-5

IF: 30.8

2022-06-03

Nature Genetics

Abstract:The substantial phenotypic heterogeneity in autism limits our understanding of its genetic etiology. To address this gap, here we investigated genetic differences between autistic individuals ( n max = 12,893) based on core and associated features of autism, co-occurring developmental disabilities and sex. We conducted a comprehensive factor analysis of core autism features in autistic individuals and identified six factors. Common genetic variants were associated with the core factors, but de novo variants were not. We found that higher autism polygenic scores (PGS) were associated with lower likelihood of co-occurring developmental disabilities in autistic individuals. Furthermore, in autistic individuals without co-occurring intellectual disability (ID), autism PGS are overinherited by autistic females compared to males. Finally, we observed higher SNP heritability for autistic males and for autistic individuals without ID. Deeper phenotypic characterization will be critical in determining how the complex underlying genetics shape cognition, behavior and co-occurring conditions in autism.

genetics & heredity
Examining Sex Differences in Autism Heritability

Sven Sandin,Benjamin H. K. Yip,Weiyao Yin,Lauren A. Weiss,Joseph D. Dougherty,Stuart Fass,John N. Constantino,Zhu Hailin,Tychele N. Turner,Natasha Marrus,David H. Gutmann,Stephan J. Sanders,Benjamin Christoffersson

DOI: https://doi.org/10.1001/jamapsychiatry.2024.0525

2024-04-17

JAMA Psychiatry

Abstract:Importance Autism spectrum disorder (ASD) is a neurodevelopmental disorder more prevalent in males than in females. The cause of ASD is largely genetic, but the association of genetics with the skewed sex ratio is not yet understood. To our knowledge, no large population-based study has provided estimates of heritability by sex. Objective To estimate the sex-specific heritability of ASD. Design, Setting, and Participants This was a population-based, retrospective analysis using national health registers of nontwin siblings and cousins from Sweden born between January 1, 1985, and December 31, 1998, with follow-up to 19 years of age. Data analysis occurred from August 2022 to November 2023. Main Outcomes and Measures Models were fitted to estimate the relative variance in risk for ASD occurrence owing to sex-specific additive genetics, shared environmental effects, and a common residual term. The residual term conceptually captured other factors that promote individual behavioral variation (eg, maternal effects, de novo variants, rare genetic variants not additively inherited, or gene-environment interactions). Estimates were adjusted for differences in prevalence due to birth year and maternal and paternal age by sex. Results The sample included 1 047 649 individuals in 456 832 families (538 283 males [51.38%]; 509 366 females [48.62%]). Within the entire sample, 12 226 (1.17%) received a diagnosis of ASD, comprising 8128 (1.51%) males and 4098 (0.80%) females. ASD heritability was estimated at 87.0% (95% CI, 81.4%-92.6%) for males and 75.7% (95% CI, 68.4%-83.1%) for females with a difference in heritability estimated at 11.3% (95% CI, 1.0%-21.6%). There was no support for shared environmental contributions. Conclusions and Relevance These findings suggest that the degree of phenotypic variation attributable to genetic differences (heritability) differs between males and females, indicating that some of the underlying causes of the condition may differ between the 2 sexes. The skewed sex ratio in ASD may be partly explained by differences in genetic variance between the sexes.

psychiatry
Isolation of the anti-inflammatory principles from Achillea millefolium (Compositae).

A. Goldberg,E. C. Mueller,E. Eigen,S. Desalva

DOI: https://doi.org/10.1002/JPS.2600580805

1969-08-01

Journal of Pharmacy and Science

Abstract:An aqueous extract of the dry flower heads of Achillea millefolium (yarrow) has been found to possess anti-inflammatory activity as measured by the mouse paw edema test. Fractionation has resulted in the isolation of a material which reduces inflammation by 35%. This concentrate is water-soluble, nonsteroidal, and has a very low order of toxicity. Physical and chemical studies show this active fraction to be a mixture of protein-carbohydrate complexes.
Sex-biased single cell genetic landscape in mice with autism spectrum disorder

Qian Zhang,Yongjie Wang,Jie Tao,Ruixue Xia,Yijie Zhang,Zhirui Liu,Jiwei Cheng

DOI: https://doi.org/10.1016/j.jgg.2023.08.012

IF: 5.723

2023-09-14

Journal of Genetics and Genomics

Abstract:Autistic spectrum disorder (ASD) is a male-biased heterogeneous neurodevelopmental disorder that affects approximately 1%–2% of the population. Prenatal exposure to valproic acid (VPA) is a recognized risk factor for ASD, but the cellular and molecular basis of VPA-induced ASD at the single-cell resolution is unclear. Here, we aimed to compare the cellular and molecular differences in the hippocampus between male and female prenatal mice with ASD at the single-cell transcriptomic level. The transcriptomes of more than 45,000 cells were assigned to 12 major cell types, including neurons, glial cells, vascular cells, and immune cells. Cell type-specific genes with altered expression after prenatal VPA exposure were analyzed, and the largest number of differentially expressed genes (DEGs) were found in neurons, choroid plexus epithelial cells, and microglia. In microglia, several pathways related to inflammation were found in both males and females, including the TNF, NF-κB, Toll-like receptor, and MAPK signaling pathways, which are important for the induction of autistic-like behavior. Additionally, we noted that several X-linked genes, including Bex1 , Bex3 , and Gria3 , were among the male-specific DEGs of neurons. This pioneering study describes the landscape of the transcriptome in the hippocampus of autistic individuals. The elucidation of sexual differences could provide innovative strategies for the prevention and treatment of ASD.

genetics & heredity,biochemistry & molecular biology
The HBV drug entecavir - effects on HIV-1 replication and resistance.

Moira A. McMahon,B. Jilek,T. Brennan,Lin Shen,Yan Zhou,M. Wind-Rotolo,Sifei Xing,S. Bhat,B. Hale,Robert W. Hegarty,C. Chong,Jun O. Liu,R. Siliciano,C. Thio

DOI: https://doi.org/10.1056/NEJMOA067710

IF: 158.5

2007-06-21

New England Journal of Medicine

Abstract:Entecavir, a drug approved by the Food and Drug Administration for the treatment of chronic hepatitis B virus (HBV) infection, is not believed to inhibit replication of human immunodeficiency virus type 1 (HIV-1) at clinically relevant doses. We observed that entecavir led to a consistent 1-log(10) decrease in HIV-1 RNA in three persons with HIV-1 and HBV coinfection, and we obtained supportive in vitro evidence that entecavir is a potent partial inhibitor of HIV-1 replication. Detailed analysis showed that in one of these patients, entecavir monotherapy led to an accumulation of HIV-1 variants with the lamivudine-resistant mutation, M184V. In vitro experiments showed that M184V confers resistance to entecavir. Until more is known about HIV-1-resistance patterns and their selection by entecavir, caution is needed with the use of entecavir in persons with HIV-1 and HBV coinfection who are not receiving fully suppressive antiretroviral regimens.
Common genetic variants are associated with increased likelihood of some co-occurring mental health conditions among autistic individuals

Adeniran Okewole,Vincent-Raphael Bourque,Mahmoud Koko,Guillaume Huguet,Anders Borglum,Jakob Grove,Sebastien Jacquemont,Simon Baron-Cohen,Varun Warrier

DOI: https://doi.org/10.1101/2024.11.11.24317097

2024-11-11

Abstract:IMPORTANCE: Autism frequently co-occurs with other mental health conditions. In the general population, these co-occurring mental health conditions are highly heritable and genetically correlated; however, the genetic architecture of co-occurring mental health conditions among autistic individuals is unclear. OBJECTIVE: To investigate the relationship between common and rare genetic variation and co-occurring mental health conditions and latent factors among autistic individuals. DESIGN: Cross-sectional SETTING: The study was conducted with the Simons Foundation Powering Autism Research (SPARK) dataset, V9 release (12 December 2022). PARTICIPANTS: Phenotypic data exploration and factor analyses was conducted in 74,204 autistic individuals, and genetic analyses were conducted in a maximum of 17,582 individuals with genetic data. MAIN OUTCOMES AND MEASURES: Genetic analysis was limited to those probands included in the SPARK iWES1 dataset [n=17,582]. SNP heritability estimates and genetic correlations were computed for three factor scores and six diagnostic categories (attention deficit hyperactivity disorder or ADHD, bipolar disorder, depression, schizophrenia, anxiety disorder and disruptive behaviour disorders or DBD) using bivariate GCTA-GREML and LDSC . Polygenic scores were generated using summary statistics from the most recent genome wide association studies (GWAS) for five traits and six conditions. Associations with factor scores and categorical diagnoses were tested separately for polygenic scores (PGS), de novo variants (DNVs) and copy number variants (CNVs). RESULTS: 56% of autistic individuals presented a co-occurring psychiatric condition. Confirmatory factor analysis identified three minimally correlated factors: a behavioural factor, cothymic factor, and a Kraepelin or thought disorder factor, with SNP heritabilities ranging from 0.21 (s.e. 0.02) for behavioural to 0.09 (s.e. 0.03) for cothymic factor. Among conditions, moderate and significant SNP heritabilites were observed for ADHD (0.18, s.e. = 0.04) and DBD (0.52, s.e. = 0.08). Moderate positive genetic correlations were found between co-occurring ADHD, DBD, anxiety and the three factors in autistic individuals and corresponding conditions in external population cohorts. PGS for ADHD, depression, and educational attainment were significantly associated with all mental health factors and some of the conditions tested. We found no evidence for an association between common variants for autism, rare CNVs, and DNVs in highly constrained genes with increased likelihood of mental health phenotypes among autistic individuals. CONCLUSION AND RELEVANCE: Among autistic individuals, some mental health conditions and all mental health factors are heritable, but have a distinct genetic architecture from autism itself.

Psychiatry and Clinical Psychology
Topical tretinoin and fetal malformations

S. Colley,I. Walpole,V. Fabian,B. Kakulas

DOI: https://doi.org/10.5694/j.1326-5377.1998.tb139031.x

1998-05-01

Abstract:To the Editor: In response to the recent article in The Lancet describing the first published case of rare eye malformations in a baby born to a mother who used the topical retinoid adapalene gel in early pregnancy, 1 we draw your attention to a similar case published by the Adverse Drug Reactions Advisory Committee in 1993.2 We describe the neuropathology of this case (the first in Australia) of severe craniofacial and central nervous system (CNS) malformations in a baby girl, born at term, whose mother had been exposed to topical retinoic acid during pregnancy. The craniofacial and CNS abnormalities in this child are consistent with deranged cranial neural crest cell migration. Similar defects have been reported in cases where mothers were exposed to oral vitamin A. 3 The craniofacial malformations were cleft palate and harelip, fused palpebral fissures, hypertelorism, a depressed nasal bridge, and deficient left nares. The CNS malformations consisted of disorganised rudimentary optic cup derivatives with optic tract dysgenesis, arrhinencephaly, agenesis of the corpus callosum, fornices and cingulate gyri, cerebellar hypoplasia, and aqueduct stenosis with hydrocephalus. The only teratogen the mother was exposed to was topical Retin-A (tretinoin 0.05%) cream, an all-trans retinoic acid, for the treatment of severe facial acne vulgaris. She applied this cream to her face twice daily for two years, including the entire period of her pregnancy. The accumulated evidence from prospective studies and a retrospective cohort study' to date does not suggest that topical tretinoin is teratogenic in humans. However, animal studies have shown the potential for a teratogenic response after the application of topical vitamin A,5 and sporadic cases of congenital malformations in association with maternal exposure to topical retinoids continue to be reported.' Multiple abnormalities are rare and in many cases the cause is not known. It must
Towards understanding sex differences in autism spectrum disorders

Karen Q Leow,Mary A Tonta,Jing Lu,Harold A Coleman,Helena C Parkington,Karen Q. Leow,Mary A. Tonta,Harold A. Coleman,Helena C. Parkington

DOI: https://doi.org/10.1016/j.brainres.2024.148877

IF: 3.61

2024-03-22

Brain Research

Abstract:Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by social deficits, repetitive behaviours and lack of empathy. Its significant genetic heritability and potential comorbidities often lead to diagnostic and therapeutic challenges. This review addresses the biological basis of ASD, focusing on the sex differences in gene expression and hormonal influences. ASD is more commonly diagnosed in males at a ratio of 4:1, indicating a potential oversight in female-specific ASD research and a risk of underdiagnosis in females. We consider how ASD manifests differently across sexes by exploring differential gene expression in female and male brains and consider how variations in steroid hormones influence ASD characteristics. Synaptic function, including excitation/inhibition ratio imbalance, is influenced by gene mutations and this is explored as a key factor in the cognitive and behavioural manifestations of ASD. We also discuss the role of micro RNAs (miRNAs) and highlight a novel mutation in miRNA-873, which affects a suite of key synaptic genes, neurexin, neuroligin, SHANK and post-synaptic density proteins, implicated in the pathology of ASD. Our review suggests that genetic predisposition, sex differences in brain gene expression, and hormonal factors significantly contribute to the presentation, identification and severity of ASD, necessitating sex-specific considerations in diagnosis and treatments. These findings advocate for personalized interventions to improve the outcomes for individuals with ASD.

neurosciences
Synthesis of genetic association studies on autism spectrum disorders using a genetic model-free approach

Ioanna Mpoulimari,Elias Zintzaras

DOI: https://doi.org/10.1097/YPG.0000000000000316

2022-06-01

Abstract:Background: Autism spectrum disorder (ASD) is a clinically and genetically heterogeneous group of neurodevelopmental disorders. Despite the extensive efforts of scientists, the etiology of ASD is far from completely elucidated. In an effort to enlighten the genetic architecture of ASDs, a meta-analysis of all available genetic association studies (GAS) was conducted. Methods: We searched in the Human Genome Epidemiology Navigator (HuGE Navigator) and PubMed for available case-control GAS of ASDs. The threshold for meta-analysis was two studies per genetic variant. The association between genotype distribution and ASDs was examined using the generalized linear odds ratio (ORG). For variants with available allele frequencies, the examined model was the allele contrast. Results: Overall, 57 candidate genes and 128 polymorphisms were investigated in 159 articles. In total 28 genetic polymorphisms have been shown to be associated with ASDs, that are harbored in 19 genes. Statistically significant results were revealed for the variants of the following genes adenosine deaminase (ADA), bone marrow stromal cell antigen-1 (CD157/BST1), Dopamine receptor D1 (DRD1), engrailed homolog 2 (EN2), met proto-oncogene (MET), methylenetetrahydrofolate reductase (MTHFR), solute carrier family 6 member 4 (SLC6A4), Synaptosomal-associated protein, 25kDa (SNAP-25) and vitamin D receptor (VDR). In the allele contrast model of cases versus healthy controls, significant associations were observed for Adrenoceptor Alpha 1B (ADRA1B), acetyl serotonin O - methyltransferase (ASMT), complement component 4B (C4B), dopamine receptor D3 (DRD3), met proto-oncogene (MET), neuroligin 4, X-linked (NLGN4), neurexin 1 (NRXN1), oxytocin receptor (OXTR), Serine/Threonine-Protein Kinase PFTAIRE-1 (PFTK1), Reelin (RELN) and Ras-like without CAAX 2 (RIT2). Conclusion: These significant findings provide further evidence for genetic factors' implication in ASDs offering new perspectives in means of prevention and prognosis.
Sex differences in brain development in fetuses and infants who are at low or high likelihood for autism

L. M. Villa,S. Hampton,E. Aydin,R. Tait,M. J. Leming,A. Tsompanidis,I. Patterson,C. Allison,T. Austin,J. Suckling,S. Baron-Cohen,R. J. Holt

DOI: https://doi.org/10.1101/2021.03.08.21251862

2021-03-11

Abstract:Abstract Background It is unknown whether the neural underpinnings of autism are present in utero . In addition, it is unclear whether typical neural sexual differentiation, which is associated with the development of autism, is evident in utero . We longitudinally investigated fetal and infant sex differences in brain structure and function, and differences in brain development in those at low and high likelihood for autism. Here, we use the term ‘typical’ interchangeably with the term ‘low-autism likelihood’. Methods Participants were longitudinally studied in utero first at 30-33 weeks of gestation, and then as infants 8-12 weeks after birth. We compared total brain volumes and resting-state functional connectivity between 15 female and 15 male low-autism likelihood fetuses (defined as having no first degree autistic relative). We also compared the brain structure and function of these 30 fetuses to a rare group of 11 fetuses (5 females and 6 males) who had an autistic mother or sibling, and therefore a higher likelihood of developing autism. Although a small sample, the high-autism likelihood group are reported as they are challenging to recruit. Additionally, we correlated sex differences in functional connectivity with autism likelihood group differences across the fetal and infant brains. Results There was a group-by-sex interaction in fetal total brain volume. Typical males, on average, showed faster total brain volume growth in the perinatal period than typical females. The high-autism likelihood group showed lower resting-state functional connectivity at both time-points compared to the typical group, and regions indicating sex differences overlapped with those associated with high-autism likelihood group differences in functional connectivity. Conclusions In utero sexual differentiation of brain structure was more pronounced in fetuses with a high likelihood for autism. Moreover, sexual differentiation of the fetal and infant brain may overlap with the neural development of autism.
Androgen levels in autism spectrum disorders: a systematic review and meta-analysis

Zhao Wang,Bohan Zhang,Chenyu Mu,Dan Qiao,Huan Chen,Yan Zhao,Huixian Cui,Rong Zhang,Sha Li

DOI: https://doi.org/10.3389/fendo.2024.1371148

IF: 6.055

2024-05-08

Frontiers in Endocrinology

Abstract:Background: Accumulating evidence suggests that the autism spectrum disorder (ASD) population exhibits altered hormone levels, including androgens. However, studies on the regulation of androgens, such as testosterone and dehydroepiandrosterone (DHEA), in relation to sex differences in individuals with ASD are limited and inconsistent. We conducted the systematic review with meta-analysis to quantitatively summarise the blood, urine, or saliva androgen data between individuals with ASD and controls. Methods: A systematic search was conducted for eligible studies published before 16 January 2023 in six international and two Chinese databases. We computed summary statistics with a random-effects model. Publication bias was assessed using funnel plots and heterogeneity using I 2 statistics. Subgroup analysis was performed by age, sex, sample source, and measurement method to explain the heterogeneity. Results: 17 case-control studies (individuals with ASD, 825; controls, 669) were assessed. Androgen levels were significantly higher in individuals with ASD than that in controls (SMD: 0.27, 95% CI: 0.06–0.48, P =0.01). Subgroup analysis showed significantly elevated levels of urinary total testosterone, urinary DHEA, and free testosterone in individuals with ASD. DHEA level was also significantly elevated in males with ASD. Conclusion: Androgen levels, especially free testosterone, may be elevated in individuals with ASD and DHEA levels may be specifically elevated in males.

endocrinology & metabolism
Genetic Causes and Modifiers of Autism Spectrum Disorder

Lauren Rylaarsdam,Alicia Guemez-Gamboa

DOI: https://doi.org/10.3389/fncel.2019.00385

2019-08-20

Frontiers in Cellular Neuroscience

Abstract:Autism Spectrum Disorder (ASD) is one of the most prevalent neurodevelopmental disorders, affecting an estimated 1 in 59 children. ASD is highly genetically heterogeneous and may be caused by both inheritable and <i>de novo</i> gene variations. In the past decade, hundreds of genes have been identified that contribute to the serious deficits in communication, social cognition, and behavior that patients often experience. However, these only account for 10–20% of ASD cases, and patients with similar pathogenic variants may be diagnosed on very different levels of the spectrum. In this review, we will describe the genetic landscape of ASD and discuss how genetic modifiers such as copy number variation, single nucleotide polymorphisms, and epigenetic alterations likely play a key role in modulating the phenotypic spectrum of ASD patients. We also consider how genetic modifiers can alter convergent signaling pathways and lead to impaired neural circuitry formation. Lastly, we review sex-linked modifiers and clinical implications. Further understanding of these mechanisms is crucial for both comprehending ASD and for developing novel therapies.

neurosciences
Exploring key genes and pathways associated with sex differences in autism spectrum disorder: integrated bioinformatic analysis

Himani Nautiyal,Akanksha Jaiswar,Prabhash Kumar Jha,Shubham Dwivedi

DOI: https://doi.org/10.1007/s00335-024-10036-5

2024-04-10

Mammalian Genome

Abstract:Autism spectrum disorder (ASD) is a heterogenous neurodevelopmental disorder marked by functional abnormalities in brain that causes social and linguistic difficulties. The incidence of ASD is more prevalent in males compared to females, but the underlying mechanism, as well as molecular indications for identifying sex-specific differences in ASD symptoms remain unknown. Thus, impacting the development of personalized strategy towards pharmacotherapy of ASD. The current study employs an integrated bioinformatic approach to investigate the genes and pathways uniquely associated with sex specific differences in autistic individuals. Based on microarray dataset (GSE6575) extracted from the gene expression omnibus, the dysregulated genes between the autistic and the neurotypical individuals for both sexes were identified. Gene set enrichment analysis was performed to ascertain biological activities linked to the dysregulated genes. Protein–protein interaction network analysis was carried out to identify hub genes. The identified hub genes were examined to determine their functions and involvement in the associated pathways using Enrichr. Additionally, hub genes were validated from autism-associated databases and the potential small molecules targeting the hub genes were identified. The present study utilized whole blood transcriptomic gene expression analysis data and identified 2211 and 958 differentially expressed unique genes in males and females respectively. The functional enrichment analysis revealed that male hub genes were functionally associated with RNA polymerase II mediated transcriptional regulation whereas female hub genes were involved in intracellular signal transduction and cell migration. The top male hub genes exhibited functional enrichment in tyrosine kinase signalling pathway. The pathway enrichment analysis of male hub genes indicates the enrichment of papillomavirus infection. Female hub genes were enriched in androgen receptor signalling pathway and functionally enriched in focal adhesion specific excision repair. Identified drug like candidates targeting these genes may serve as a potential sex specific therapeutics. Wortmannin for males, 5-Fluorouracil for females had the highest scores. Targeted and sex-specific pharmacotherapies may be created for the management of ASD. The current investigation identifies sex-specific molecular signatures derived from whole blood which may serve as a potential peripheral sex-specific biomarkers for ASD. The study also uncovers the possible pharmacological interventions against the selected genes/pathway, providing support in development of therapeutic strategies to mitigate ASD. However, experimental proofs on biological systems are warranted.

genetics & heredity,biochemistry & molecular biology,biotechnology & applied microbiology
The Genetic Architecture of Autism Spectrum Disorders (asds) and the Potential Importance of Common Regulatory Genetic Variants

David Saffen

DOI: https://doi.org/10.1007/s11427-012-4336-5

2015-01-01

Abstract:Currently, there is great interest in identifying genetic variants that contribute to the risk of developing autism spectrum disorders (ASDs), due in part to recent increases in the frequency of diagnosis of these disorders worldwide. While there is nearly universal agreement that ASDs are complex diseases, with multiple genetic and environmental contributing factors, there is less agreement concerning the relative importance of common vs rare genetic variants in ASD liability. Recent observations that rare mutations and copy number variants (CNVs) are frequently associated with ASDs, combined with reduced fecundity of individuals with these disorders, has led to the hypothesis that ASDs are caused primarily by de novo or rare genetic mutations. Based on this model, large-scale whole-genome DNA sequencing has been proposed as the most appropriate method for discovering ASD liability genes. While this approach will undoubtedly identify many novel candidate genes and produce important new insights concerning the genetic causes of these disorders, a full accounting of the genetics of ASDs will be incomplete absent an understanding of the contributions of common regulatory variants, which are likely to influence ASD liability by modifying the effects of rare variants or, by assuming unfavorable combinations, directly produce these disorders. Because it is not yet possible to identify regulatory genetic variants by examination of DNA sequences alone, their identification will require experimentation. In this essay, I discuss these issues and describe the advantages of measurements of allelic expression imbalance (AEI) of mRNA expression for identifying cis-acting regulatory variants that contribute to ASDs.
Comprehensive systematic review and meta-analysis of the association between common genetic variants and autism spectrum disorder

Yulian Fang,Yaqiong Cui,Zhaoqing Yin,Mengzhu Hou,Pan Guo,Hanjie Wang,Nan Liu,Chunquan Cai,Mingbang Wang

DOI: https://doi.org/10.1016/j.gene.2023.147723

IF: 3.913

2023-12-15

Gene

Abstract:Background: Autism spectrum disorder (ASD) is neurodevelopmental disorder characterized by stereotyped behavior and deficits in communication and social interactions. To date, numerous studies have investigated the associations between genetic variants and ASD risk. However, the results of these published studies lack a clear consensus. In the present study, we performed a systematic review on the association between genetic variants and ASD risk. Meanwhile, we conducted a meta-analysis on available data to identify the association between the single nucleotide polymorphisms (SNPs) of candidate genes and ASD risk. Methods: We systematically searched public databases including English and Chinese from their inception to August 1, 2022. Two independent reviewers extracted data and assessed study quality. Odds ratio and 95 % confidence interval were used as effect indexes to evaluate the association between the SNPs of candidate genes and the risk of ASD. Heterogeneity was explored through subgroup, sensitivity, and meta-regression analyses. Publication bias was assessed by using Egger's and Begg's tests for funnel plot asymmetry. In addition, TSA analysis were performed to confirm the study findings. Results: We summarized 84 SNPs of 32 candidate genes from 81 articles included in the study. Subsequently, we analyzed 16 SNPs of eight genes by calculating pooled ORs, and identified eight significant SNPs of contactin associated protein 2 (CNTNAP2), methylentetrahydrofolate reductase (MTHFR), oxytocin receptor (OXTR), and vitamin D receptor (VDR). Results showed that seven SNPs, including the CNTNAP2 rs2710102 (homozygote, heterozygote, dominant and allelic models) and rs7794745 (heterozygote and dominant models), MTHFR C677T (homozygote, heterozygote, dominant, recessive and allelic models) and A1298C (dominant and allelic models), OXTR rs2254298 (homozygote and recessive models), VDR rs731236 (homozygote, dominant, recessive and allelic models) and rs2228570 (homozygote and recessive models), were showed to be correlated with an increased ASD risk. By contrast, the VDR rs7975232 was correlated with a decreased the risk of ASD under the homozygote and allelic models. Conclusion: Our study summarized research evidence on the genetic variants of ASD and provides a broad and detailed overview of ASD risk genes. The C677T and A1298C polymorphisms of MTHFR, rs2710102 and rs7794745 polymorphisms of CNTNAP2, rs2254298 polymorphism of OXTR, and rs731236 and rs2228570 polymorphisms of VDR were genetic risk factors. The rs7975232 polymorphism of VDR was a genetic protective factor for ASD. Our study provides novel clues to clinicians and healthcare decision-makers to predict ASD susceptibility.
Sex-specific impact of prenatal androgens on social brain default mode subsystems

Michael V. Lombardo,Bonnie Auyeung,Tiziano Pramparo,Angélique Quartier,Jérémie Courraud,Rosemary J. Holt,Jack Waldman,Amber N. V. Ruigrok,Natasha Mooney,Richard A. I. Bethlehem,Meng-Chuan Lai,Prantik Kundu,Edward T. Bullmore,Jean-Louis Mandel,Amélie Piton,Simon Baron-Cohen

DOI: https://doi.org/10.1038/s41380-018-0198-y

IF: 11

2018-08-13

Molecular Psychiatry

Abstract:Abstract Early-onset neurodevelopmental conditions (e.g., autism) affect males more frequently than females. Androgens may play a role in this male-bias by sex-differentially impacting early prenatal brain development, particularly neural circuits that later develop specialized roles in social cognition. Here, we find that increasing prenatal testosterone in humans is associated with later reduction of functional connectivity between social brain default mode (DMN) subsystems in adolescent males, but has no effect in females. Since testosterone can work directly via the androgen receptor (AR) or indirectly via the estrogen receptor through aromatase conversion to estradiol, we further examined how a potent non-aromatizable androgen, dihydrotestosterone (DHT), acts via the AR to influence gene expression in human neural stem cells (hNSC)—particularly for genes of high-relevance for DMN circuitry. DHT dysregulates a number of genes enriched for syndromic causes of autism and intellectual disability and for genes that in later development are expressed in anatomical patterns that highly correspond to the cortical midline DMN subsystem. DMN-related and DHT-affected genes (e.g., MEF2C ) are involved in a number of synaptic processes, many of which impact excitation-inhibition balance. Androgens have male-specific prenatal influence over social brain circuitry in humans and may be relevant towards explaining some component of male-bias in early-onset neurodevelopmental conditions.

biochemistry & molecular biology,neurosciences,psychiatry

Stanley M. Rogoff, 1922-1979.

Polycystic ovary syndrome and autism: A test of the prenatal sex steroid theory

Associations Between Sex Hormone Levels and Autistic Traits in Infertile Patients With Polycystic Ovary Syndrome and Their Offspring

Prematurity and Genetic Liability for Autism Spectrum Disorder

Contribution of autosomal rare and variants to sex differences in autism

Genetic correlates of phenotypic heterogeneity in autism

Examining Sex Differences in Autism Heritability

Isolation of the anti-inflammatory principles from Achillea millefolium (Compositae).

Sex-biased single cell genetic landscape in mice with autism spectrum disorder

The HBV drug entecavir - effects on HIV-1 replication and resistance.

Common genetic variants are associated with increased likelihood of some co-occurring mental health conditions among autistic individuals

Topical tretinoin and fetal malformations

Towards understanding sex differences in autism spectrum disorders

Synthesis of genetic association studies on autism spectrum disorders using a genetic model-free approach

Sex differences in brain development in fetuses and infants who are at low or high likelihood for autism

Androgen levels in autism spectrum disorders: a systematic review and meta-analysis

Genetic Causes and Modifiers of Autism Spectrum Disorder

Exploring key genes and pathways associated with sex differences in autism spectrum disorder: integrated bioinformatic analysis

The Genetic Architecture of Autism Spectrum Disorders (asds) and the Potential Importance of Common Regulatory Genetic Variants

Comprehensive systematic review and meta-analysis of the association between common genetic variants and autism spectrum disorder

Sex-specific impact of prenatal androgens on social brain default mode subsystems